Research Articles | Page 23 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Haploidentical Transplant with Post-Transplant Cyclophosphamide for Acute Myeloid Leukaemia and Myelodysplastic Syndromes Patients: The Role of Previous Lines of Therapy Jan 2024 Mediterranean Journal of Hematology and Infectious Diseases Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS)
Haploidentical stem cell transplantation (haplo-SCT) represents the main alternative for children with inherited bone marrow failure syndrome (I-BMF) lacking a matched donor. This retrospective study, conducted on behalf of the EBMT SAAWP and PDWP, aims t Jun 2024 American Society of Clinical Oncology Educational Book Myelodysplastic Syndromes (MDS)
Haploidentical hematopoietic stem cell transplantation in aplastic anemia: a systematic review and meta-analysis of clinical outcome on behalf of the severe aplastic anemia working party of the European group for blood and marrow transplantation (SAAWP of Apr 2020 Bone Marrow Transplantation Aplastic Anemia
Haploidentical hematopoietic stem cell transplantation in aplastic anemia: a systematic review and meta-analysis of clinical outcome on behalf of the severe aplastic anemia working party of the European group for blood and marrow transplantation (SAAWP of Oct 2020 Bone Marrow Transplantation Aplastic Anemia
Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide Apr 2020 Blood Advances Aplastic Anemia
Guideline-based indicators for adult patients with myelodysplastic syndromes Aug 2020 Blood Advances Myelodysplastic Syndromes (MDS)
Guadecitabine (SGI-110) in patients with intermediate or high-risk myelodysplastic syndromes: phase 2 results from a multicentre, open-label, randomised, phase 1/2 trial Jun 2019 The Lancet Haematology Myelodysplastic Syndromes (MDS)
Granulocyte transfusions in severe aplastic anemia Jun 2024 Haematologica Aplastic Anemia
Granulocyte transfusions in severe aplastic anemia Dec 2023 Haematologica Aplastic Anemia
Good but not good enough: Clinical trial participation of patients with myelodysplastic syndromes Aug 2020 Cancer Myelodysplastic Syndromes (MDS)